A chimeric type l/type 2 poliovirus (v510), in which the antigenic site l (Agl) of poliovirus type 1 (PV-I) Mahoney was replaced by the corresponding site of poliovirus type 2 (PV-2) Lansing, is known to be neurovirulent for mice and neutralized by both type 1 and type 2 monoclonal antibodies. Neutralizationescape mutants to monoclonal antibodies specifically recognizing the PV-2 sequence were obtained from v510. The nucleotide sequence and the mouse neurovirulence of mutants were determined. Amino acid substitutions obtained inside the replaced sequence, at positions 95 and 99, and outside this site, at positions 93 or 104, rendered the virus attenuated for mice. One of the escape mutants harboured a deletion of the entire substituted nonapeptide sequence in v510. This particular virus, which is a PV-1 Mahoney lacking the natural Agl loop, does not react with PV-2-specific monoclonal antibodies, has a ts phenotype, is heatlabile and is devoid of neurovirulence for mice.
Poliovirus, a member of the Picornaviridae family, has been investigated intensively in recent years as a model for the understanding of viral antigenicity (Hogle et al., 1985; Horaud et al., 1987; Minor, 1987; Wimmer et al., 1986) and virulence (Almond, 1987; Racaniello, 1987) . Antigenic hybrids of poliovirus were constructed by making use of a mutagenesis cartridge on genomic cDNAs (Martin et al., 1988; Murdin & Wimmer, 1989; Murray et al., 1988a, b) . A nonapeptide sequence corresponding to the neutralization antigenic site I (Ag 1) (residues 94 to 102 of the structural polypeptide VP1) of the Mahoney strain of poliovirus type 1 (PV-1) has been replaced by the equivalent sequence of the Lansing strain of poliovirus type 2 (PV-2) (Martin et al., 1988; Murray et al., 1988a) . The substitution of the nine amino acid long sequence of PV-2, in which only six amino acids differ from those of PV-1, rendered the mouse-avirulent PV-1 Mahoney pathogenic for mice. This result indicated that the Lansing sequence, functioning as an immunogenic site (Minor et al., 1986) , is required for poliovirus virulence in mice.
PV-1/PV-2 chimeric virus v510 (Martin et al., 1988) contains only six amino acids specific for the PV-2 Agl in a PV-1 structural environment and its three-dimensional structure has been solved (unpublished results). It therefore represents an ideal tool to analyse the structural 0000-9845 © 1991 SGM and the functional role of the individual PV-2-specific amino acids in the mouse-adapted phenotype. The sensitivity of v510 to PV-2-specific neutralizing monoclonal antibodies (MAbs) allowed the selection of neutralization-escape variants with mutations occurring in the Agl domain. Mutants that escaped inactivation by two MAbs, HO2 (UytdeHaag & Osterhaus, 1985) and Iio (Crainic et al., 1983) , recognizing two different epitopes of the Agl of PV-2 Lansing and v510 (Martin et al., 1988) , were thus selected. In this report, a representative sample of the mutants obtained is presented and the effect of these mutations on viral antigenic characters, the mouse-adapted phenotype and in vitro phenotypic markers is described. In addition, one of the mutants selected with MAb HO2 has the entire PV-2-specific sequence (nine amino acids) deleted. A phenotypic analysis of this particular mutant is also reported.
Six clones of v510 (511 to 516) have been isolated by plaque purification, from which neutralization-resistant mutants were selected as follows. Of each of the six clones, 10 3, 10 4, 105 and 106 p.f.u, were incubated for 2 h at 37 °C with an equal volume of either MAb HO2 (ascites fluid at a 1 : 100 dilution) or MAb Iio (undiluted supernatant fluid). HEp-2c cells were then infected with this mixture and covered with 0"9~o agar medium containing the respective MAb at a tenth of the above 
* Virus reactivity with each MAb was determined by a neutralization index (NI) test by calculating the difference of the log virus titre in TCIDs0 in the absence and in the presence of the specified MAb (Crainic et al., 1983) . NI > 2 indicates the presence (+), and NI < 2 indicates the absence (-) of the neutralization epitope. The antigenic site recognized by each MAb (named according to Minor et al., 1986; Minor, 1987) is indicated between parentheses.
1" Variants H were selected from v510 in the presence of MAb HOz and clones D were isolated in the presence of MAb Iio. concentration. After 3 days at 37 °C, cells were stained with neutral red and individual plaques were picked. Neutralization-resistant mutants were isolated in all cases at a frequency of about 10 -4, which is in agreement with values previously reported (Blondel et al., 1986; Minor et al., 1986) . Two rounds of plaque purification in the absence of MAb were then performed for each mutant to eliminate parental type virus.
The antigenic characterization of variants (Table 1) showed that each mutant was resistant to neutralization by the selecting MAb and most of them were also resistant to neutralization by the second MAb. However, some mutants were resistant to MAb Iio but not to MAb HO2 (511D1 and 516D1). This confirms that the two MAbs are specific for different epitopes. The neutralization pattern of v510 by MAbs specific for antigenic sites 2a, 2c and 3b (Minor et al., 1986; Minor, 1987) was not altered by mutations affecting Agl reactivity. The fact that the reactivity of 513DI with MAb Io (Ag3b) was modified is probably due to the unselected mutation Thr 60 -* Lys that was found in VP3 (result not shown).
The neurovirulence for mice of each variant was quantitatively determined (Table 2 ). All antigenic variants were less neurovirulent than the parental strain. The RNA sequence of the region coding for Agl was determined for each mutant (Table 2) . After injection of each virus to groups of six mice, the RNA nucleotide sequence of virus isolated from the spinal cord of one of the paralysed mice was determined. In each case, it was found to be identical to that of the inoculated virus in the Agl-coding region, showing that paralysis was relevant to inoculation of the corresponding virus.
The virulence of v510 for mice was reduced, but not abolished, by VP1 mutations Arg 100 ~ His or Ala 101 Thr. The mutation of Arg 100, one of the most exposed residues at the surface of the capsid (unpublished results), therefore affected the mouse-adapted phenotype only slightly. Other workers have reported that substituting Leu or Ser for Arg 100 in VPI of PV-2 Lansing resulted in fully neurovirulent isolates (La Monica et al., 1987) . The nature of the amino acid residue at position 100 is therefore not critical, although not totally without influence, since several amino acids can apparently be accommodated at this position with slight or no effect on mouse neurovirulence. Other mutations responsible for the attenuation of mouse neurovirulence were at residues 95 and 99 and also, surprisingly, at residues 93 and 104, i.e. outside the substituted Agl sequence. The critical Lys 99 ~ Glu mutation corroborates results obtained from similar studies with PV-2 Lansing (La Monica et al., 1987) . Residue 93 is located in ]~-strand B, N-terminal to the loop constituting Agl (Hogle et al., 1985) . An Asp 93 --, Val change in a PV-1/PV-2 chimera has also been reported to result in loss of mouse virulence (Martin et al., 1988) . These results reveal a strong involvement of amino acid 93 in the mouse neurovirulence phenotype. Residue 104 is located in/~-strand C, C-terminal to the loop (Hogle et al., 1985) . The Leu 104 -Arg mutation rendered v510 devoid of virulence (LDs0 > 108 p.f.u) for mice.
All amino acid substitutions observed in the avirulent or strongly attenuated isolates, i.e. viruses with a mutation at position 93, 95, 99 or 104 of VP 1, introduced a modification of charge in VP1. These changes are likely to affect the structure of the Agl loop. It can therefore be concluded that the amino acids at these positions and most probably the resulting conformational structure of this sequence determine the mouse-adapted phenotype. On the other side, we observed that a spontaneous mutant of v510 with a substitution Va187 --, Ala, in the/~-sheet preceding the Agl loop, exhibited a reduced neurovirulence for mice (LD50 = 105"s p.f.u.) (data not shown). The reduced neurovirulence might be due to a modification of the conformation of the Agl loop induced by the Va187 ~ Ala mutation although we do not expect the loop structure to be dramatically altered, because this variant is still neutralized by both the HOz and Iio MAbs. Alternatively, the reduced neurovirulence could be due to another determinant that has not * Numbering refers to amino acid positions in the VP1 polypeptide of PV-1. Bold face corresponds to the substituted PV-2 sequence in the chimera v510 and mutations concerning these amino acids. The residues that differ between Mahoney and Lansing are underlined. RNA sequencing was performed as described by Geliebter et aL (1986) and covered the region of nucleotides 2720 to 2810 corresponding approximately to amino acids 80 to 110 of VP1.
t Number of paralysed (P) over inoculated (I) 3-week-old Swiss Webster mice inoculated by the intracerebral route with 1 x l0 s p.f.u, of virus. The dose of neurovirulent virus (loglo) that caused paralysis or death in 50~ of mice (LDso) was calculated 21 days after inoculation of six mice per 10-fold serial dilution. (_+0-4) 3.4 3.1 4.8 * Virus-infected HeLa cell monolayers were stained after 3 days of incubation at 37°C under agar overlay. Mean (+S.E.M.) of 100 measurements obtained in two independent experiments.
t Mean values of two independent experiments (for all the experiments, standard deviation is 0.1 or 0.2).
:~ Reproductive capacity at supraoptimal temperature (RCT) was calculated as the difference of the log virus titre (TCIDs0) at optimal (37 °C) and each of the supraoptimal (39.5 °C or 40 °C) temperatures. Mean of two independent experiments. RCT > 2 corresponds to ts phenotype.
been identified so far. These hypotheses are under investigation.
It is interesting to note ( Table 3 ) that all escape mutants examined, irrespective of the amino acid change, showed a small plaque phenotype. Most of them were however at least as heat-stable at 45 °C as their large plaque parental virus, and only two of them, 515H1 and 511D1, were heat-labile. Two mutants were temperature-sensitive (ts), as judged by lack of growth at non-permissive temperatures (39 °C for 511D2 and 40 °C for 513H~). However, there was no absolute correlation between their in vitro phenotypic characters and neurovirulence for mice.
Among the neutralization-escape variants isolated and sequenced, an unexpected mutant (516H0 was found, which harboured a deletion of the whole PV-2-specific nucleotide sequence (27 nucleotides) of the chimera v510. To our knowledge, such a large deletion in the capsid polypeptide of a picornavirus has never before been reported. This mutant was analysed in detail. The lower M r of its VP1 capsid protein (Fig. 1 ) is in agreement with the shortening of the polypeptide sequence. The deletion of nine amino acids, which corresponds exactly to the loss of the Lansing sequence of v510, was accompanied by loss of mouse neurovirulence (Table 2) . Its strong loss of infectivity at 45 °C is indicative of a heat-labile capsid. Moreover, it produced small plaques and showed a ts phenotype (Table 3) .
The complete deletion of the B-C loop of VP1 corresponding to Agl (Hogle et al., 1985) additional mutation occurred elsewhere in the genome during the selection procedure, it can be concluded that the deletion of the entire Agl loop did not affect the viability of the virus, although this mutant exhibited phenotypic changes. We recently obtained by genetic engineering a similarly deleted virus which is fully viable. Comparison of phenotypic properties of both deleted viruses is in progress (unpublished results). Although poliovirus has a very tight crystalline structure, the Agl loop appears to be extremely permissive. A viable virus has also been obtained by insertion of a heterologous hexapeptide at VP1 position 100 of the analogous loop in PV-3 Sabin (Colb6re- Garapin et al., 1988) . It was also shown that substitution of the nine amino acids of PV-1 Sabin Agl by a series of heterologous epitopes of various lengths (up to 18 residues) resulted in viable viruses Evans et al., 1989; Jenkins et al., 1990) . It is intriguing that the deletion observed in the 516H 1 virus capsid corresponds exactly to the substituted amino acid sequence of its chimeric parent v510. We cannot determine a statistical value for selection of the deleted virus as a neutralization-escape variant from the PV-1/PV-2 chimera with PV-2-specific MAbs. However, one was selected among approximately 30 escape variants in this case. It should be noted that such a virus has never been reported among many wild or attenuated PV variants selected with MAbs specific for homologous Agl (Blondel et al., 1986; Minor et al., 1986) . This suggests that the stability of heterologous antigenic sequences at the surface of the capsid of antigenic hybrid viruses which may be used for the development of new vaccines should be thoroughly tested.
As previous studies showed that the PV-2-specific nonapeptide of the Agl-coding region determined neurovirulence of PV-1 Mahoney in mice (Martin et al., 1988; Murray et al., 1988a) , the avirulent phenotype of the deleted virus confirmed the involvement of this sequence in the mouse-adapted phenotype. It has been suggested that this sequence might be involved in the binding of poliovirus to the mouse nerve cell receptor (La Monica et al., 1987; Martin et al., 1988; Murray et al., 1988a) . However, it is not known whether Agl acts as a factor of neurovirulence for primates. As determinants of poliovirus neurovirulence in mice and in primates are not necessarily correlated, we are currently performing neurovirulence tests of the deleted virus in monkeys, in order to analyse the role of this sequence in the neurovirulence of poliovirus for primates.
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